Form 4: UHS Executive Chairman Miller Acquires 14,153 Shares

Universal Health Services' Executive Chairman, Alan B. Miller, reported the acquisition of 14,153 Class B Common Stock units through a restricted stock grant.

Summary

• Alan B. Miller, Executive Chairman, Director, and 10% Owner of Universal Health Services, Inc. (UHS), acquired 14,153 shares of Class B Common Stock.
• The acquisition occurred on March 26, 2026, at a price of $0 per share, indicating a restricted stock unit grant.
• These restricted stock units will vest ratably on March 26, 2027, March 26, 2028, March 26, 2029, and March 26, 2030.
• Following this transaction, Mr. Miller directly beneficially owns 1,796,166 shares of Class B Common Stock.
• Indirect beneficial ownership includes shares held by various family trusts and a foundation, totaling 202,075 shares, though Mr. Miller disclaims beneficial ownership of these.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management's interests with long-term shareholder value, without indicating any immediate operational or financial changes.

Positives

• The grant of restricted stock units to Executive Chairman Alan B. Miller aligns his interests with long-term shareholder value.
• The acquisition of 14,153 Class B Common Stock units at a $0 price indicates a compensation grant, a common practice for executive incentives.

Future Outlook

The restricted stock units granted to Alan B. Miller will vest ratably over four years, from March 26, 2027, to March 26, 2030, indicating a long-term incentive structure.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units to a key executive like Alan B. Miller is a standard practice in the healthcare services industry, aiming to retain talent and align executive incentives with long-term company performance. This type of compensation is prevalent across publicly traded companies, including competitors such as HCA Healthcare (HCA) and Tenet Healthcare (THC), which also utilize equity-based awards to incentivize their leadership.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) with a multi-year vesting schedule for executive compensation is a common and widely accepted practice across the S&P 500, including major healthcare providers.
• Companies like HCA Healthcare and Community Health Systems (CYH) frequently grant similar equity awards to their top executives, often with vesting periods ranging from three to five years, to promote long-term commitment and performance.
• The $0 price for the acquired shares is typical for RSU grants, as the value is derived from the underlying stock price at vesting.

Related Party Transactions

• Alan B. Miller disclaims beneficial ownership of Class B Common Stock held indirectly by The Abby Miller King 2011 Family Trust (55,763 shares), The Alan and Jill Miller Foundation (8,623 shares), The Marc Daniel Miller 2011 Family Trust (59,900 shares), The Marni Spencer 2011 Family Trust (55,763 shares), Abby Miller King 2024 GRAT (9,418 shares), Abby Miller King 2025 GRAT (24,295 shares), Marc Daniel Miller 2024 GRAT (13,963 shares), Marc Daniel Miller 2025 GRAT (24,295 shares), Marni Spencer 2024 GRAT (9,418 shares), and Marni Spencer 2025 GRAT (24,295 shares).

Stakeholder Impact

• Shareholders: The grant of restricted stock units to the Executive Chairman can be seen as a positive for shareholders, as it aligns management's long-term incentives with the company's performance and stock appreciation.
• Management/Executives: Alan B. Miller receives additional equity compensation, increasing his stake and potential future wealth tied to the company's success.

Next Steps

• Vesting of restricted stock units on March 26, 2027.
• Vesting of restricted stock units on March 26, 2028.
• Vesting of restricted stock units on March 26, 2029.
• Vesting of restricted stock units on March 26, 2030.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (restricted stock unit grant) and does not provide new information that would fundamentally alter the investment thesis for Universal Health Services. While it indicates continued alignment of executive interests with shareholders, it's not a catalyst for a 'buy' or 'sell' recommendation. Investors should 'hold' and consider this as part of ongoing executive incentive programs.

Keywords

Universal Health Services, UHS, Alan B. Miller, Form 4, Insider Trading, Restricted Stock Units, Executive Compensation, Stock Grant, Beneficial Ownership, Healthcare Services